Flowgene Overview

  • Founded
  • 2000
  • Status
  • Private
  • Employees
  • 1
  • Latest Deal Type
  • Seed
  • Investors
  • 2

Flowgene General Information


Developer of innovative optical systems designed to allow faster and efficient DNA sequencing. The company's innovative optical systems are based on a gel-sieving matrix and can be used on various applications, like fluorescence detection, flux cytometry, chips technology and raman effect detection, enabling diagnostic market, food industry and drugs and explosive detectors to carry out their operations in an advanced technological way.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • De Clermont-limagne
  • 63360 Saint Beauzire
  • France
+33 04 00 00 00 00
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Flowgene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 01-Jan-2000 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue

Flowgene Executive Team (1)

Name Title Board Seat Contact Info
Bruno Bellussiere President

Flowgene Investors (2)

To view Flowgene‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Sofimac Investment Managers Venture Capital Minority 000 0000 000000 0
G1J Ile-de-France Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial